The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas

American Journal of Surgical Pathology

Volumn 28, Issue 11, 2004, Pages 1499-1505

  Ramalingam, Preetha ^a   Malpica, Anais ^a   Silva, Elvio G ^a   Gershenson, David M ^a   Liu, Jinsong L ^a   Deavers, Michael T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

AFP; C kit; CK7; Clear cell carcinoma; EMA; Endometrioid carcinoma; Immunohistochemistry; Leu M1; Ovary; WT1; Yolk sac tumor

Indexed keywords

ALPHA FETOPROTEIN; CD15 ANTIGEN; CYTOKERATIN; CYTOKERATIN 7; EPITHELIAL MEMBRANE ANTIGEN; STEM CELL FACTOR RECEPTOR; TUMOR MARKER; WT1 PROTEIN;

ADENOCARCINOMA; ARTICLE; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOID CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CARCINOMA; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; TECHNIQUE; YOLK SAC TUMOR;

ADENOCARCINOMA, CLEAR CELL; ALPHA-FETOPROTEINS; ANTIGENS, CD15; CA-15-3 ANTIGEN; CARCINOMA, ENDOMETRIOID; DIAGNOSIS, DIFFERENTIAL; ENDODERMAL SINUS TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-7; KERATINS; OVARIAN NEOPLASMS; PROTO-ONCOGENE PROTEINS C-KIT; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 7044237528     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000138179.87957.32     Document Type: Article

References (37)

1. Arber DA, Tamayo R, Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29:498-504.
2. Ballotta MR, Bianchini E, Borghi L, et al. Clear cell carcinoma simulating the 'endometrioid-like variant' of yolk sac tumor. Pathologica. 1995;87: 87-90.
3. Battifora H, Sheibani K, Tubbs RR, et al. Antikeratin antibodies in tumor diagnosis: distinction between seminoma and embryonal carcinoma. Cancer. 1984;54:843-848.
4. Cathro HP, Stoler MH. Expression of cytokeratins 7 and 20 in ovarian neoplasia. Am J Clin Pathol. 2002;117:944-951.
5. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13:962-972.
6. Clement PB, Young RH, Scully RE. Endometrioid-like variant of ovarian yolk sac tumor: a clinicopathological analysis of eight cases. Am J Surg Pathol. 1987;11:767-778.
7. Damjanov I, Osborn M, Miettinen M. Keratin 7 is a marker for a subset of trophoblastic cells in human germ cell tumors. Arch Pathol Lab Med. 1990;114:81-83.
8. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA. Ovarian hepatoid yolk sac tumours: morphological, immunohistochemical and ultrastructural features. Histopathology. 1999;34:462-469.
9. Duggan MA, Robertson DI. The cytokeratin profiles of ovarian common 'epithelial' tumors. Eur J Gynaecol Oncol. 1989;10:73-79.
10. Eglen DE, Ulbright TM. The differential diagnosis of yolk sac tumor and seminoma: usefulness of cytokeratin, alpha-fetoprotein, and alpha-1-antitrypsin immunoperoxidase reactions. Am J Clin Pathol. 1987;88:328-332.
11. Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol. 2001;116:246-252.
12. Higuchi Y, Kouno T, Teshima H, et al. Serous papillary cystadenocarcinoma associated with alpha-fetoprotein production. Arch Pathol Lab Med. 1984;108:710-712.
13. Horiuchi A, Osada R, Nakayama K, et al. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53. Gynecol Oncol. 1998;70:295-299.
14. Hosomi M, Sagawa S, Kotou Y. Alpha-fetoprotein-producing adenocarcinoma of the ureter. Urol Int. 1992;48:226-227.
15. Inoue M, Kyo S, Fujita M, et al. Coexpression of the c-kit receptor and the stem cell factor in gynecological tumors. Cancer Res. 1994;54:3049-3053.
16. Izquierdo MA, Van der Valk P, Van Ark-Otte J, et al. Differential expression of the c-kit proto-oncogene in germ cell tumours. J Pathol. 1995;177: 253-258.
17. Kamoi S, Ohaki Y, Mori O, et al. A case of ovarian endometrioid adenocarcinoma with yolk sac tumor component in a postmenopausal woman. APMIS. 2002;110:508-514.
18. Konishi I, Fujii S, Kataoka N, et al. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein. Int J Gynecol Pathol. 1988;7:182-189.
19. Kurman RJ, Morris HJ. Endodermal sinus tumor of the ovary: a clinical and pathologic analysis of 71 cases. Cancer. 1976;38:2404-2419.
20. Lertprasertsuke N, Tsutsumi Y. Alpha-fetoprotein-producing urachal adenocarcinoma. Acta Pathol Jpn. 1991;41:318-326.
21. Lopez J, Malpica A, Deavers M, et al. Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary: A case report and review of the literature. Ann Diagn Pathol. 2003;7: 300-305.
22. Manivel C, Wick MR, Dehner LP. Transitional (cylindric) cell carcinoma with endodermal sinus tumor-like features of the nasopharynx and paranasal sinuses: clinicopathologic and immunohistochemical study of two cases. Arch Pathol Lab Med. 1986;110:198-202.
23. McCluggage WG. Recent advances in immunohistochemistry in gynaecological pathology. Histopathology. 2002;40:309-326.
24. Miettinen M, Virtanen I, Talerman A. Intermediate filament proteins in human testis and testicular germ-cell tumors. Am J Pathol. 1985;120:402-410.
25. Miettinen M, Wahlstrom T, Virtanen I, et al. Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins. Am J Surg Pathol. 1985;9:640-651.
26. Niehans GA, Manivel C, Copland GT, et al. Immunohistochemistry of germ cell and trophoblastic neoplasms. Cancer. 1988;62:1113-1123.
27. Nogales FF, Bergeron C, Carvia RE, et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am J Surg Pathol. 1996;20:1056-1066.
28. Nojima T, Kojima T, Kato H, et al. Alpha-fetoprotein-producing acinar cell carcinoma of the pancreas. Hum Pathol. 1992;23:828-830.
29. Nomura K, Miyasaka Y, Murae M, et al. Ovarian mucinous cystadenocarcinoma producing alpha-fetoprotein: a case report. Acta Pathol Jpn. 1992;42:372-375.
30. Rutgers JL, Young RH, Scully RE. Ovarian yolk sac tumor arising from an endometrioid carcinoma. Hum Pathol. 1987;18:1296-1299.
31. Shimizu M, Toki T, Takagi Y, et al. Immunohistochemical detection of the Wilms' tumor gene (WT1) in epithelial ovarian tumors. Int J Gynecol Pathol. 2000;19:158-163.
32. Spagnolo DV, Michie SA, Crabtree GS, et al. Monoclonal anti-keratin (AE1) reactivity in routinely processed tissue from 166 human neoplasms. Am J Clin Pathol. 1985;84:697-704.
33. Tian Q, Frierson HF Jr, Krystal GW, et al. Activating c-kit gene mutations in human germ cell tumors. Am J Pathol. 1999;154:1643-1647.
34. Ulbright TM, Roth LM, Brodhecker CA. Yolk sac differentiation in germ cell tumors: a morphologic study of 50 cases with emphasis on hepatic, enteric, and parietal yolk sac features. Am J Surg Pathol. 1986;10:151-164.
35. Vang R, Whitaker BP, Farhood AI, et al. Immunohistochemical analysis of clear cell carcinoma of the gynecologic tract. Int J Gynecol Pathol. 2001;20:252-259.
36. Wick MR, Swanson PE, Manivel C. Placental-like alkaline phosphatase reactivity in human tumors. Hum Pathol. 1987;18:946-954.
37. Zirker TA, Suva EG, Morris M, et al. Immunohistochemical differentiation of clear-cell carcinoma of the female genital tract and endodermal sinus tumor with the use of alpha-fetoprotein and Leu-M1. Am J Clin Pathol. 1989;91:511-514.